Clinical Trial Update: STAT3 Inhibitor for Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of a STAT3 inhibitor in patients with advanced solid tumors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• STAT3 inhibitor

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancer, Solid Tumor | Phase 1 | Status: COMPLETED